T. Rowe Price Associates’s THERAGENICS CORP TGX Stock Holding History

T. Rowe Price Associates’s Portfolio TGX Stock Details TGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-18,011	Closed	-$39K	–	2571
2013 Q3	$39K	Hold	18,011	–	–	﹤0.01%	2439
2013 Q2	$37K	Buy	+18,011	New	+$32.2K	﹤0.01%	2412

T. Rowe Price Associates's TGX Position: Q4 2013 in Review

T. Rowe Price Associates sold out of THERAGENICS CORP (TGX) in Q4 2013, closing a stake of 18,011 shares — an estimated $39K sold.

T. Rowe Price Associates first reported a position in TGX in Q2 2013 and held it in 2 quarters. The position peaked at $39K in Q3 2013. 0 funds tracked by Wall St. Rank hold TGX as of Q4 2013.

T. Rowe Price Associates reported no remaining THERAGENICS CORP position as of Q4 2013 after selling out during the quarter.
T. Rowe Price Associates sold 18,011 THERAGENICS CORP shares in Q4 2013, an estimated $39K.
T. Rowe Price Associates first reported a position in THERAGENICS CORP in Q2 2013 and held it in 2 quarters.
T. Rowe Price Associates's THERAGENICS CORP position peaked at $39K in Q3 2013.
0 funds tracked by Wall St. Rank held THERAGENICS CORP as of Q4 2013.

Based on T. Rowe Price Associates's 13F filing for Q4 2013, filed 14 Feb 2014.